slides · global inventory
Cite Precedent
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 2,146
Current window 1,051-1,080
Pages 72
Rows per page 30
Slide function
1,051-1,080 of 2,146
12
The slide contains a direct quote from a legal judgment regarding misappropriation of assets.Ramaco Resources, Inc. (METC) · Wolfpack Research
Research note Short seller Loop · Cost Of Inaction1 hit
17
The slide lists bibliographic citations for three distinct studies, each with a brief summary of the research aim, methodology, and findings.PMV Pharmaceuticals (PMVP) · Wolfpack Research
Research note Short seller 1 hit
11
The slide details specific financial settlements and legal claims against Triller.authID Inc. (AUID) · 61_White_Diamond_Research
Research note Short seller Beat · Cite Precedent1 hit
52
The slide uses historical news headlines to illustrate the regulatory and safety failure of the drug Seldane.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The VictoryLoop · The Reveal1 hit
53
The slide uses a historical precedent (Seldane/terfenadine recall) to frame the severity of a current drug's (pitolisant) safety profile, highlighting specific death and exposure statistics.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The VictoryLoop · The Reveal1 hit
62
The slide highlights the specific chemical challenge of nitrogen basicity in piperidine rings and the potential for fluorine to modulate pKa for improved safety.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Victory1 hit
63
The slide uses a screenshot of a blog post with red underlines to emphasize key quotes about hERG activity and piperidine.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Victory1 hit
72
The slide highlights BF2.649 (pitolisant) with a red box to emphasize its drug-likeness profile compared to other failed candidates.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
91
The slide uses a Q&A transcript format to validate the thesis that the H3 receptor class is fundamentally flawed.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
95
The slide uses expert testimony to establish a precedent of failure in the H3 receptor space, specifically contrasting J&J's robust trials with Bioprojet's pitolisant.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
12
The slide uses external media citations to establish the company's credibility and historical performance.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller Beat · Allegations of accounting irregularitiesLoop · Aha Moment1 hit
39
The slide details the 'founding customer' relationship between Intel and Lasertec, and the subsequent reliance on Ushio for light sources.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller Beat · Technical issues with Lasertec's products1 hit
44
The slide uses a Wikipedia excerpt to frame ASML as a monopolist created through public funding and subsequent acquisition of US-developed technology.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller Beat · Technical issues with Lasertec's products1 hit
82
The slide title mentions 'Gross Profit Margin' (売上総利益率) but the content is entirely about inventory (棚卸資産).Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 1 hit
88
The slide contrasts KLA and Lam Research's audit reports with the explicit fraud case of MagnaChip.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 1 hit
104
The slide contrasts LDP (Laser-assisted Discharge Plasma) used by Lasertec with LPP (Laser Produced Plasma) used by ASML, citing a specific academic paper to validate the critique of LDP's contamination issues.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 1 hit
107
The slide uses a bilingual (Japanese/English) format to present technical evidence regarding tin debris damage mechanisms.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 1 hit
135
The slide presents anecdotal evidence from an industry insider to support a thesis about customer dissatisfaction and technical failure.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 1 hit
142
The slide uses red boxes and arrows to highlight key technical improvements (Urashima light source and High-NA support) within the original English press release text.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller Beat · Conclusion and call to action1 hit
280
The slide presents qualitative evidence in a Q&A format to support a thesis about KLA's competitive positioning against Lasertec.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 1 hit
284
The slide argues that the CHIPS Act forces companies receiving subsidies to source equipment from US-based suppliers, creating a competitive disadvantage for non-US firms like Lasertec.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 1 hit
285
The slide presents a series of Q&A-style expert opinions, highlighting the competitive disadvantage Lasertec faces due to US government pressure on major chip manufacturers to favor US-based suppliers.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 1 hit
161
The slide uses a historical precedent to frame current battery company claims as part of a recurring pattern of fraud.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction1 hit
134
The slide uses a direct quote and an abstract excerpt to build credibility for the argument that GH therapy has negative metabolic consequences.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
328
The slide uses a Q&A transcript format to support the thesis that the competitor product is unnecessary or inferior.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
392
The slide uses direct quotes and Q&A excerpts to build a case against the safety of the drug Vykat in the context of PWS treatment.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
414
The slide uses Q&A transcript format to build credibility for the thesis that generic substitution is common practice among specialists.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
116
Contains highlighted text segments within the quotes.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
325
The slide uses a direct quote to frame the current market situation as overpriced and vulnerable to disruption, drawing an analogy to the Hepatitis C drug market.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
191
The slide uses a Q&A format to present expert testimony.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit